RHOEN-KLINIKUM AG (RHK.DE) Stock Price, Forecast & Analysis
Europe - FRA:RHK - DE0007042301 - Common Stock
RHK.DE Key Statistics, Chart & Performance
The current stock price of RHK.DE is 12.2 EUR. In the past month the price increased by 5.17%.
RHK.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EMEIS.PA | EMEIS SA | N/A | 2.17B | ||
| CLARI.PA | CLARIANE SE | N/A | 1.21B | ||
| GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 986.89M | ||
| GHC.MI | GAROFALO HEALTH CARE SPA | 14.51 | 471.29M | ||
| M12.DE | M1 KLINIKEN AG | 15.64 | 288.71M | ||
| LNA.PA | LNA SANTE | 11.31 | 258.11M | ||
| MED.DE | MEDICLIN AG | 4.93 | 166.25M | ||
| LIK.DE | LIMES SCHLOSSKLINIKEN AG | 22.08 | 100.34M | ||
| MAK.DE | MATERNUS-KLINIKEN AG | N/A | 23.07M | ||
| EIF.DE | MEDNATION AG | 16 | 9.48M |
Related stock screener links
About RHK.DE
Company Profile
Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 18,821 full-time employees. The firm operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
Company Info
RHOEN-KLINIKUM AG
Schlossplatz 1
Bad Neustadt an der Saale BAYERN DE
Employees: 18821
Phone: 499771650
RHOEN-KLINIKUM AG / RHK.DE FAQ
Can you describe the business of RHOEN-KLINIKUM AG?
Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 18,821 full-time employees. The firm operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
What is the current price of RHK stock?
The current stock price of RHK.DE is 12.2 EUR.
Does RHK stock pay dividends?
RHOEN-KLINIKUM AG (RHK.DE) has a dividend yield of 0.83%. The yearly dividend amount is currently 0.
What is the ChartMill rating of RHOEN-KLINIKUM AG stock?
RHK.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Where is RHOEN-KLINIKUM AG (RHK.DE) stock traded?
RHK.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the analyst forecast for RHK.DE stock?
7 analysts have analysed RHK.DE and the average price target is 14.45 EUR. This implies a price increase of 18.44% is expected in the next year compared to the current price of 12.2.
RHK.DE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to RHK.DE. When comparing the yearly performance of all stocks, RHK.DE turns out to be only a medium performer in the overall market: it outperformed 48.29% of all stocks.
RHK.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to RHK.DE. RHK.DE has an excellent financial health rating, but there are some minor concerns on its profitability.
RHK.DE Financial Highlights
Over the last trailing twelve months RHK.DE reported a non-GAAP Earnings per Share(EPS) of 0.56. The EPS decreased by -19.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.28% | ||
| ROA | 2.02% | ||
| ROE | 2.9% | ||
| Debt/Equity | 0.09 |
RHK.DE Forecast & Estimates
7 analysts have analysed RHK.DE and the average price target is 14.45 EUR. This implies a price increase of 18.44% is expected in the next year compared to the current price of 12.2.
For the next year, analysts expect an EPS growth of 9.14% and a revenue growth 5.98% for RHK.DE